Gastric and Gastroesophageal Junction Adenocarcinoma - Current and Future Players

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Related Reports
3 Market Outlook
3.1 Global Markets
3.1.1 Forecast
3.1.2 Drivers and Barriers ­ Global Issues
4 Current and Future Players
4.1 Overview
4.2 Trends in Corporate Strategy
4.3 Company Profiles
4.3.1 Bristol­Myers Squibb
4.3.2 Eli Lilly and Company
4.3.3 Merck & Co.
4.3.4 Roche
4.3.5 Taiho Pharmaceutical
4.3.6 Sumitomo Dainippon Pharma
5 Appendix
5.1 Bibliography
5.2 Abbreviations
5.3 Methodology
5.4 Forecasting Methodology
5.4.1 Hospitalized MRSA Patients
5.4.2 Percentage of Drug­Treated MRSA Patients
5.4.3 Drugs Included in Each Therapeutic Class
5.4.4 Launch, Label Expansion, and Patent Expiry Dates
5.4.5 General Pricing Assumptions
5.4.6 Individual Drug Assumptions
5.4.7 Generic Erosion
5.4.8 Pricing of Pipeline Agents
5.5 Primary Research ­ KOLs Interviewed for This Report
5.6 Primary Research ­ Prescriber Survey
5.7 About the Authors
5.7.1 Author and Therapy Area Director
5.7.2 Author
5.7.3 Epidemiologist
5.7.4 Global Director of Therapy Analysis and Epidemiology
5.7.5 Global Head of Healthcare
5.8 About GlobalData
5.9 Disclaimer
About us
MarketResearchReports.biz is the most comprehensive collection of market research
reports. MarketResearchReports.Biz services are specially designed to save time and money
for our clients. We are a one stop solution for all your research needs, our main offerings
are syndicated research reports, custom research, subscription access and consulting